JP2018087189A5 - - Google Patents

Download PDF

Info

Publication number
JP2018087189A5
JP2018087189A5 JP2017237151A JP2017237151A JP2018087189A5 JP 2018087189 A5 JP2018087189 A5 JP 2018087189A5 JP 2017237151 A JP2017237151 A JP 2017237151A JP 2017237151 A JP2017237151 A JP 2017237151A JP 2018087189 A5 JP2018087189 A5 JP 2018087189A5
Authority
JP
Japan
Prior art keywords
carbonyl
phenyl
amino
cyano
butanoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017237151A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018087189A (ja
JP6922712B2 (ja
Filing date
Publication date
Priority claimed from JP2017132416A external-priority patent/JP6269888B1/ja
Application filed filed Critical
Publication of JP2018087189A publication Critical patent/JP2018087189A/ja
Publication of JP2018087189A5 publication Critical patent/JP2018087189A5/ja
Application granted granted Critical
Publication of JP6922712B2 publication Critical patent/JP6922712B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017237151A 2016-07-07 2017-12-11 医薬用途 Expired - Fee Related JP6922712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016134847 2016-07-07
JP2016134847 2016-07-07
JP2017132416A JP6269888B1 (ja) 2016-07-07 2017-07-06 医薬用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017132416A Division JP6269888B1 (ja) 2016-07-07 2017-07-06 医薬用途

Publications (3)

Publication Number Publication Date
JP2018087189A JP2018087189A (ja) 2018-06-07
JP2018087189A5 true JP2018087189A5 (enExample) 2020-07-09
JP6922712B2 JP6922712B2 (ja) 2021-08-18

Family

ID=61074787

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017132416A Active JP6269888B1 (ja) 2016-07-07 2017-07-06 医薬用途
JP2017237151A Expired - Fee Related JP6922712B2 (ja) 2016-07-07 2017-12-11 医薬用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017132416A Active JP6269888B1 (ja) 2016-07-07 2017-07-06 医薬用途

Country Status (1)

Country Link
JP (2) JP6269888B1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230390303A1 (en) * 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor
CN114790186A (zh) * 2021-01-25 2022-07-26 武汉人福创新药物研发中心有限公司 作为ep4拮抗剂的稠环化合物及其制备方法和用途
WO2022247862A1 (zh) * 2021-05-28 2022-12-01 南京明德新药研发有限公司 苯并螺杂环衍生物及其应用
CN113234012B (zh) * 2021-06-01 2023-04-25 上海巽田科技股份有限公司 一种3-甲氨基吡啶及其衍生物或其盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756333B2 (en) * 1998-03-13 2003-01-09 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6211197B1 (en) * 1998-10-07 2001-04-03 Merck Frosst Canada & Co. Prostaglandin receptor ligands
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
GB0031302D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Napthalene derivatives
KR20040022238A (ko) * 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
WO2016088903A1 (en) * 2014-12-05 2016-06-09 Takeda Pharmaceutical Company Limited Heterocyclic compounds

Similar Documents

Publication Publication Date Title
JP2018100297A5 (enExample)
RU2017124136A (ru) Трициклическое спиро-соединение
US10501442B2 (en) Quinoline derivative
ES2985986T3 (es) Conjugado biciclo para tratar el cáncer
JP6885390B2 (ja) Ａｘｌ阻害剤と免疫チェックポイント阻害剤とを組み合わせて投与することを特徴とする癌治療のための医薬
JP2018080173A5 (enExample)
JP2024514879A (ja) Ｍｅｋ阻害剤及びその使用
CN116554168A (zh) Cxcr4抑制剂及其用途
JP2018087189A5 (enExample)
CA2904794A1 (en) Modulators of the eif2alpha pathway
JP7025022B2 (ja) 骨髄系由来抑制細胞関連障害の治療のための方法
ES2922898T3 (es) Inhibidores multifuncionales de las rutas biológicas de MEK/PI3K y mTOR/MEK/PI3K y métodos terapéuticos que usan los mismos
JP2010536842A5 (enExample)
RU2014150860A (ru) Режим дозирования pi-3 киназы
JP2010507626A (ja) Ｖｅｇｆｒ３阻害剤としての大環状キナゾリン誘導体
JP2025514724A (ja) Ｄｄｘ５タンパク質に結合するカンプトセシン誘導体およびそのプロドラッグ
AU2010336256B2 (en) Antitumor Agent or Postoperative Adjuvant Chemotherapeutic Agent for Hepatocellular Carcinoma Treatment
EP4245301A1 (en) Cancer treatment by combined use of ep4 antagonist and immune checkpoint inhibitor
WO2018222975A1 (en) Methods for the treatment of cancer
HK40001093B (en) Quinoline derivative
HK40001093A (en) Quinoline derivative